KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Accumulated Depreciation (2020 - 2023)

Ginkgo Bioworks Holdings' Accumulated Depreciation history spans 4 years, with the latest figure at $118.5 million for Q2 2023.

  • For Q2 2023, Accumulated Depreciation rose 51.47% year-over-year to $118.5 million; the TTM value through Jun 2023 reached $118.5 million, up 51.47%, while the annual FY2022 figure was $92.8 million, 51.93% up from the prior year.
  • Accumulated Depreciation reached $118.5 million in Q2 2023 per DNA's latest filing, up from $107.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $118.5 million in Q2 2023 to a low of $33.8 million in Q4 2020.
  • Average Accumulated Depreciation over 4 years is $77.6 million, with a median of $78.2 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation: surged 80.74% in 2021, then skyrocketed 51.47% in 2023.
  • A 4-year view of Accumulated Depreciation shows it stood at $33.8 million in 2020, then surged by 80.74% to $61.1 million in 2021, then surged by 51.93% to $92.8 million in 2022, then increased by 27.72% to $118.5 million in 2023.
  • Per Business Quant, the three most recent readings for DNA's Accumulated Depreciation are $118.5 million (Q2 2023), $107.3 million (Q1 2023), and $92.8 million (Q4 2022).